ArticleBioactive materials2022

A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer.

Duo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.